Live Breaking News & Updates on Arbutus Biopharma Corporation Nasdaq

Stay updated with breaking news from Arbutus biopharma corporation nasdaq. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Arbutus to Participate in Jefferies Global Healthcare Conference

29.05.2024 - WARMINSTER, Pa., May 29, 2024 (GLOBE NEWSWIRE) - Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with chronic hepatitis B . ....

Lisam Caperelli , Arbutus Biopharma Corporation Nasdaq , Biopharma Corporation ,

Arbutus to Present Imdusiran Data at EASL Congress 2024

WARMINSTER, Pa., May 22, 2024 Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with. ....

United States , N Acetylgalactosamine Galnac , Kosh Agarwal , Fung Yuen , Lisam Caperelli , Arbutus Biopharma Corporation Nasdaq , Securities Exchange , World Health Organization , Biopharma Corporation , European Association , Poster Tour , Looking Statements , Securities Act , Securities Exchange Act , Arbutu Annual Report , Arbutu Quarterly Reports ,

Arbutus to Participate in Two Upcoming Investor Conferences

Arbutus to Participate in Two Upcoming Investor Conferences
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Lisam Caperelli , Arbutus Biopharma Corporation Nasdaq , Biopharma Corporation ,

Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update

End-of-treatment data from two Phase 2a combination clinical trials with imdusiran to be presented at the EASL Congress in June 2024 Preliminary data from the single-dose portion of the AB-101-001. ....

United States , Katie Anderson , Ram Bhamidimarri , Ronaldg Nahass , Deana Antoniello , Kosh Agarwal , Anita Kohli , Jeong Heo , Gavin Cloherty , Louise Bussey , Naim Alkhouri , Shariec Ganchua , Stuartc Gordon , Christinel Espiritu , Tatiana Burda , Stuart Roberts , Kevin Gray , Tuant Nguyen , Timothy Eley , Michaelj Mcelhaugh , Mark Anderson , Jacinta Holmes , Barinthus Bio , Tiffany Fortney , Karend Sims , Tilly Varughese ,

Arbutus Announces Retirement of Chief Scientific Officer, Michael J. Sofia, PhD, Effective December 31, 2024

WARMINSTER, Pa., May 02, 2024 Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with. ....

Michaelj Mcelhaugh , Lisam Caperelli , Securities Exchange , Arbutus Biopharma Corporation Nasdaq , Biopharma Corporation , Chief Scientific Officer , Michael Sofia , Interim President , Chief Executive Officer , Looking Statements , Securities Act , Securities Exchange Act , Arbutu Annual Report , Arbutu Quarterly Reports ,